Real-world Non-Interventional Post-Authorization Safety Study of Long-Term Use of Burosumab in Children and Adolescents with X-linked Hypophosphatemia: First Interim Analysis
THERAPEUTIC ADVANCES IN CHRONIC DISEASE(2024)
关键词
burosumab,patient registry,post-authorization safety study,safety,X-linked hypophosphatemia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要